Search

Your search keyword '"Hardy, John"' showing total 6,736 results

Search Constraints

Start Over You searched for: Author "Hardy, John" Remove constraint Author: "Hardy, John"
6,736 results on '"Hardy, John"'

Search Results

51. Emerge

52. Potential for Chemistry in Multidisciplinary, Interdisciplinary, and Transdisciplinary Teaching Activities in Higher Education

54. MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study

55. New insights into the genetic etiology of Alzheimer’s disease and related dementias

60. Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia.

61. Non-coding variability at the APOE locus contributes to the Alzheimer's risk.

62. The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease

63. Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability

64. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers.

65. Protein network analysis reveals selectively vulnerable regions and biological processes in FTD

68. APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson’s disease

69. Multi-modality machine learning predicting Parkinson’s disease

71. Controlled Sr(ii) ion release from

72. Adaptive Long-Read Sequencing Reveals GGC Repeat Expansion in ZFHX3 Associated with Spinocerebellar Ataxia Type 4

73. A blood-based multi-pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups

74. Stimuli-responsive biomaterials for drug delivery

76. Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification

77. The Rise of the Modern Intelligence State

78. Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study

79. In Silico Toxicity Screening as a Tool for the Development of Sustainable Electronics, Exemplified with Organic Light‐Emitting Electrochemical Cells.

80. Poly(2-Hydroxyethyl Methacrylate) Hydrogel-Based Microneedles for Bioactive Release.

81. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

82. Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

83. The Amyloid-β Pathway in Alzheimer’s Disease

84. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.

85. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study

86. CXCR4 involvement in neurodegenerative diseases.

87. Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer’s disease pathogenesis

88. An Aged Canid with Behavioral Deficits Exhibits Blood and Cerebrospinal Fluid Amyloid Beta Oligomers.

89. Correction: Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies.

90. Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies

91. Large-scale visualisation of α-synuclein oligomers in Parkinson's disease brain tissue

92. Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification

93. A blood‐based multi‐pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups

99. Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study

100. Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases.

Catalog

Books, media, physical & digital resources